RxDoctor Payments Data

Juan Abonia

Allergy & Immunology · Cincinnati, OHNPI 1457300915

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,850 of the $11,691 with a category attached, or 75.7%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 79.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $9,300 and has fallen 99.3% since, to $61 in 2024.

$11,691in general payments, 2019–2025

Across 10 payments — averaging $1169.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$9K
  • Shire North American Group Inc$2K
  • Tersera Therapeutics LLC$61
  • Amgen$20
$502,993in research payments, 2019–2025

Across 8 payments — averaging $62,874 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$486K
  • E.r. Squibb & Sons, L.L.C.$17K

What the payments were for

  • Consulting fees$2,76024%
  • Speaking & faculty fees$8,85076%
  • Food & beverage$200%
  • Education$611%

General payments by program year

19
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,691 in reported general payments places this provider in the 75th percentile of 128 allergy & immunology providers in Ohio.

See all allergy & immunology providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab15$112,128
Fasenra PenBenralizumab17$96,792
Hydroxychloroquine Sulfate14$390
Famotidine19$322

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →